BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NXP900 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of NXP900\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07315113-2153@assetmemo.bio
DTSTAMP:20261121T005411Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:NXP900: Phase 1 readout est. (NCT07315113)
DESCRIPTION:NXP900\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study of
  NXP900 With Osimertinib in Subjects With Advanced\, EGFR-Mutated Non-Smal
 l Cell Lung Cancer\nEstimated primary completion: December 2026. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/nxp900#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT07315113
URL:https://assetmemo.bio/drug/nxp900#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05873686-2153@assetmemo.bio
DTSTAMP:20261121T005411Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:NXP900: Phase 1 readout est. (NCT05873686)
DESCRIPTION:NXP900\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Phase 
 1 Clinical Study of NXP900 in Subjects With Advanced Cancers\nEstimated pr
 imary completion: March 2027. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/nxp900#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT05873686
URL:https://assetmemo.bio/drug/nxp900#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07784959-2153@assetmemo.bio
DTSTAMP:20261121T005411Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:NXP900: Phase 1 readout est. (NCT07784959)
DESCRIPTION:NXP900\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study of
  NXP900 With Lorlatinib in ALK+ Lung Cancer\nEstimated primary completion:
  August 2027. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/nxp900#
 upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0778
 4959
URL:https://assetmemo.bio/drug/nxp900#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
